| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 98.8 | 110.4 | 87.6 |
| Other income | 0.2 | 0.3 | 1.3 |
| Total income | 99.0 | 110.7 | 88.9 |
| Profit before exceptional items & tax | -8.5 | 4.0 | 10.8 |
| Profit before tax | -8.5 | 4.0 | 10.8 |
| Net profit | -7.9 | 1.0 | 8.0 |
| Operating margin | -8.6% | 3.6% | 12.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +12.80% |
|---|---|
| Operating profit, year on year | -191.60% |
| Operating profit, quarter on quarter | -335.10% |
BSE results filing, NSE: GEMAROMA. Figures extracted from the filing.
Gem Aromatics Ltd: key numbers
- Share price
- ₹158.93
- Market cap
- ₹830.2 Cr
- Revenue (annual)
- ₹366.5 Cr
- Net profit (annual)
- ₹1.42 Cr
- P/E (TTM)
- -57.5×Sector 37.5×
- Promoter holding
- 57.45%+0.44% QoQ
- FII holding
- 0.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gem Aromatics Ltd
All →Gem Aromatics Acquisition Worth ₹225.2 Cr
Gem Aromatics Limited is acquiring Krystal Ingredients Private Limited for ₹225.21 Crore through the conversion of a loan into equity.
- Value
- ₹225.2 Cr
Gem Aromatics Acquisition
Gem Aromatics Limited approved converting existing inter-company loans into equity shares of its wholly-owned subsidiary, Krystal Ingredients Private Limited, to strengthen the subsidiary's capital base.
- Execution
- Within one month from receipt of requisite approvals
Gem Aromatics Annual Report
The company submitted a revised Annual Report for FY 2025-26, replacing inadvertently attached unfinalized annexures. No content changes were made to the report.
Gem Aromatics Investor Presentation: Key Takeaways
Gem Aromatics reports Q1FY27 standalone revenue growth of 9% YoY. Strategy focuses on scaling the new Dahej facility and expanding into higher-value specialty molecules like cooling agents and phenol derivatives.
Gem Aromatics Earnings Call: Key Takeaways
Gem Aromatics reports Q4 FY26 sequential recovery with consolidated revenue of ₹110cr (up 40% QoQ). Strategy focuses on diversifying from mint into high-margin clove derivatives and cooling agents via the new Dahej facility.
Gem Aromatics Earnings Call: Key Takeaways
Gem Aromatics reports sequential recovery in Q4FY26 with revenue of ₹110 Cr (Consolidated). Focus is on ramp-up at the greenfield Dahej facility and higher-value specialty molecules.